News

Beginning this month, PBMs in California must prioritize health plan interests over their own, and CVS Caremark’s CalPERS contract includes $250 million in performance guarantees.

CHOP partners with Soar Autism Center to enhance early autism care access, reducing wait times and providing integrated therapy services for families.

A recent study found that TikTok videos about breast cancer screening created by physicians are more accurate and reliable than those made by nonphysicians or private clinics, highlighting both the platform’s growing role in health education and persistent quality gaps.

Discover the effectiveness of sonic sleep aids, revealing which audio tools truly enhance sleep quality and which may not deliver on their promises.

Existing medications for narcolepsy aim for symptom control. But therapies in development are targeting the specific mechanism of the disease and the brain’s natural sleep-wake cycle.

A recent study reveals ustekinumab outperforms adalimumab and secukinumab in drug survival for psoriasis, guiding treatment decisions for patients.

Five experimental drugs show promise in significantly lowering lipoprotein(a). The furthest along is pelacarsen, with phase 3 results expected in the first half of this year, and regulatory filings in the second half of this year.

A nationwide randomized study showed that risk-based breast cancer screening safely detects cancer while reducing unnecessary screening for low-risk women and is favored by most patients over annual mammograms.

In a wide-ranging interview, Mitchell discussed the Purchaser Business Group Health’s health data demonstration project, employer fiduciary responsibility, consequences of the end of enhanced Affordable Care Act subsidies and direct contracting.

The PBM association also appointed Brendan Buck chief communications officer. Both Marin and Buck begin Jan. 20, 2026.

Independence Blue Cross announces three out of five 2026 Clinical Care Innovation Grants to enhance healthcare access and outcomes through innovative projects by leading health systems.

Despite widespread exposure to breast cancer misinformation that heightened fear in many patients, a survey found it did not lead to increased treatment nonadherence.

A phase 3 trial offers new evidence that an immunotherapy drug may outperform chemotherapy for acral melanoma, a rare subtype long underrepresented in clinical research.

Post-hoc analysis shows potential of biomarkers for identifying pancreatic patients who respond to treatment.

AI transforms how Americans navigate the complex healthcare system, offering timely support and enhancing decision-making for patients and providers alike.

Numerous medical societies and experts have labeled the CDC’s decision as dangerous and confusing.

A new analysis suggests that Medicaid expansion was linked to lower mortality for patients with resectable non-small cell lung cancer, with survival benefits emerging gradually and persisting over time.

In 2024, 91% of patients receiving care through the Ryan White HIV/AIDS Program were virally suppressed, underscoring the program’s role in improving HIV outcomes.

Alexa B. D’Angelo, Ph.D., M.P.H. and Jeremiah Johnson share their predictions for HIV challenges in 2026.

Telehealth transforms mental health care for Medicare patients, replacing in-person visits while increasing overall spending, according to recent research findings.

Experts predict shifts in U.S. healthcare for this year, focusing on affordability, consumer demands, mental health equity and the essential role of doulas.

The oral versions may set records in 2026, and glucagon-like peptide 1 (GLP-1) drugs will pick up even more momentum as medications for cardiovascular risk reduction as well as obesity, predict experts.

New guidelines from the Health Resources and Services Administration (HRSA) aim to reduce cost and access barriers for detecting human papillomavirus, which is preventable.

People taking glucagon-like peptide 1 (GLP-1) drugs were 36% less likely to develop colorectal cancer than those taking aspirin, according to a real-world, head-to-head study.

Transthyretin amyloid cardiomyopathy causes heart failure through protein buildup in heart muscle. Three FDA-approved disease-specific therapies are available, but high costs limit access.

Primary care must ensure that patients have access to the full spectrum of preventive tools, including nutrition services, to reduce chronic conditions and avoid their associated costs.

New research reveals how gastric cancer cells exploit WNT signaling for growth, revealing potential treatment targets to combat this deadly disease.